Powell Saul R, Samuel Samson Mathews, Wang Ping, Divald Andras, Thirunavukkarasu Mahesh, Koneru Srikanth, Wang Xuejun, Maulik Nilanjana
Department of Medicine, The Feinstein Institute for Medical Research and the Albert Einstein College of Medicine, New Hyde Park, NY, USA.
J Mol Cell Cardiol. 2008 Mar;44(3):618-21. doi: 10.1016/j.yjmcc.2007.12.009. Epub 2008 Jan 26.
This study examined the hypothesis that the ubiquitin proteasome system (UPS) degrades proteins damaged by exposure to hyperglycemia. Experimental hyperglycemia was induced in male rats by treatment with streptozotocin. After 30 days, echocardiography confirmed the presence of cardiomyopathy as ejection fraction, fractional shortening, and diastolic function (E/A ratio) were decreased, and chamber diameter was increased in hyperglycemic animals. Proteasome non-ATP-dependent chymotryptic activity was increased over 2-fold in hyperglycemic hearts, but the ATP-dependent activity was decreased and levels of ubiquitinated proteins were increased. Protein levels of the PA28alpha of the 11S-activator ring were increased by 128% and the PA28beta subunit increased by 58% in the hyperglycemic hearts. The alpha3 subunit of the 20S-proteasome was increased by 82% while the catalytic beta5 subunit was increased by 68% in hyperglycemic hearts. Protein oxidation as indicated by protein carbonyls was significantly higher in hyperglycemic hearts. These studies support the conclusion that the UPS becomes dysfunctional during long term hyperglycemia. However, 11S-activated proteasome was increased suggesting a response to oxidative protein damage and a potential role for this form of the proteasome in a cardiac pathophysiology.
本研究检验了泛素蛋白酶体系统(UPS)降解因暴露于高血糖而受损蛋白质的假说。通过链脲佐菌素处理雄性大鼠诱导实验性高血糖。30天后,超声心动图证实高血糖动物出现心肌病,表现为射血分数、缩短分数和舒张功能(E/A比值)降低,心腔直径增加。高血糖心脏中蛋白酶体非ATP依赖性糜蛋白酶活性增加超过2倍,但ATP依赖性活性降低,泛素化蛋白质水平增加。在高血糖心脏中,11S激活环的PA28α蛋白水平增加了128%,PA28β亚基增加了58%。20S蛋白酶体的α3亚基在高血糖心脏中增加了82%,而催化性β5亚基增加了68%。以蛋白质羰基表示的蛋白质氧化在高血糖心脏中显著更高。这些研究支持以下结论:在长期高血糖期间UPS功能失调。然而,11S激活的蛋白酶体增加,提示对氧化蛋白质损伤的反应以及这种形式的蛋白酶体在心脏病理生理学中的潜在作用。